Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion type Assertion NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_head.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion wasGeneratedBy ECO_0000203 NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_provenance.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion wasDerivedFrom lhgdn-20090331 NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_provenance.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion SIO_000772 18707544 NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_provenance.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion evidence source_evidence_literature NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_provenance.
- NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_assertion description "[NZ-1 neutralizes the interaction between podoplanin and CLEC-2, which may lead to the development of therapeutic antibodies against podoplanin-dependent cancer metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102806.RAU8e0FZgexZM5cUgx13gKpB1Orf4DZM0ugAWIA0szntQ130_provenance.